Your medicine or device can receive a digital companion on a Class IIa platform that clinical teams already use in their care pathways. What patients report there comes back to you as real-world evidence.
Build personalized digital companions for your product, deliver the therapy inside the clinics already treating your patients, and read the results back as structured data.
Complex regimens often break down in everyday life. With myoncare, patients have a digital companion that guides them through their treatment: what to take and when, what to watch for, and what to report back.
Every completed task generates structured, scored data. Collected anonymously and at scale, it becomes robust evidence for research and reimbursement submissions.
Manage trial participants, electronic patient-reported outcomes (ePROs) and visit schedules in one place. The data comes directly from participants rather than from a site visit, and the cohort logic that defines the study also governs the export.
Patients on your therapy are rarely treated by a single team. myoncare can connect the providers involved in their care like hospital department, specialist practice and referring practice in a structured network that stays with patients across the whole patient journey.
You provide the therapy, myoncare provides the certified platform, and your clinical partners deliver it to the patients they already treat.
Set the program up yourself in the content management system, or work with our content team. The app and the certifications are already in place.
Your therapy is delivered the way it was designed: at every site and for every patient. That keeps the evidence comparable across the whole population.
Patients join by scanning a QR code at the clinic that already treats them. Enrolment happens where the patients already are.
What patients report becomes structured, anonymized data. At scale, it supports research and reimbursement submissions and meets the MDR requirements for post-market surveillance.
Anonymized data scales where identified data stalls: you get results across the whole population without ever seeing an individual. That is what opens clinics to your program.
Data is transmitted encrypted and only decrypted on the patient’s smartphone or the treating clinician’s device. Your program never becomes a place where patient data can leak.
Your instance runs on an EU server with a provider we have validated, with no setup work on your side. Our GDPR compliance is confirmed and certified by the Institute for IT Law (IITR), so your data protection review has an audited answer it can point to.
Evidence is generated from aggregated analyses, not individual records. What data is made available, and on what legal basis, is agreed per project between the participating institutions. That framework is what makes participation possible for clinics.
You start on a certification you did not have to build, budget for or wait years to obtain:
Patients join at the point of care, by QR code at the clinic already treating them. No app to market, no program that stalls because nobody signed up.
Every completed task generates structured data. Evidence you would otherwise commission emerges from a program that is already running, usable for research, reimbursement dossiers and post-market surveillance under the EU MDR.
myoncare supports clinicians and patients across almost every indication, in Europe and the US. One supplier relationship, one security review, one integration per clinic, reused at every launch instead of rebuilt per product.
The content management system is no-code: your teams create and change patient content themselves, in real time, without development work or release cycles. Multi-language support makes entering a new market a content task, not a development project.
Sites connect myoncare to what they already run: HL7 and FHIR interfaces to hospital information and tumour documentation systems, plus LOINC-conformant mapping for wearable data. myoncare is also prepared for the European Health Data Space (EHDS).
Trusted by
myoncare is a CE-marked health platform consisting of a web app & desktop app for careteams for clinical teams and a smartphone or web app for patients. Digital content can be created in the backend and then sent to patients in the smartphone app. From their dashboard, clinical teams can manage their patients, filter by a range of criteria, track health and communicate with patients directly, by video call or chat.
Patients are enrolled at the point of care by QR code. Sites and satellites mirror how care actually happens: a hospital department can lead the care pathway, while external clinicians join as satellites and see only the patients assigned to them or whose QR code they have scanned. The backend is built to be operated by clinical users without programming knowledge, and connects via HL7 for patient and diagnosis data, FHIR for exchange with external health systems, and LOINC-conformant mapping for wearable data. That way sites do not have to re-enter what they already hold. myoncare is also prepared to support the European Health Data Space (EHDS) through secure, interoperable and patient-controlled data exchange.
Not necessarily. The content management system (CMS) is the heart of myoncare: content can be created, given automation rules and combined into care pathways. The interface is deliberately designed so that it can also be operated by users without programming knowledge. If you would rather not build content yourself, you can refer your patients into an existing health program from our subsidiary myon.clinic, which is available to patients in Europe. Alternatively, our content team can support you in creating your own content. Talk to us and we will outline the right route for your program.
Classifying our platform as a Class IIa medical device brings a number of advantages, both for us as the manufacturer and for you as the user. For you it means added safety, because myoncare is developed and continuously improved in line with the latest quality and safety standards. This is assured by regular audits by TÜV SÜD Product Service GmbH. Classification as a Class IIa medical device is also a basic prerequisite for digital health applications to be used for monitoring and diagnostic support. Successful Class IIa certification does, however, require considerable financial and staffing investment.
The myoncare platform is certified under the MDR (Regulation (EU) 2017/745) as a Class IIa medical device. Our data protection meets the requirements of the EU GDPR, confirmed and certified by the Institute for IT Law (IITR). In the US, the myoncare healthcare platform is listed in accordance with FDA standards. In addition, myoncare holds ISO 13485:2016 (quality management for medical devices), ISO/IEC 27001:2022 (information security management system), ISO 14971 (application of risk management to medical devices), IEC 62304 (software life cycle processes), IEC 82304 (health software product safety) and IEC 62366 (usability engineering for medical devices). The standards and certifications listed refer to the quality management system (QMS) and the information security management system (ISMS) of ONCARE GmbH, which is responsible for developing the myoncare health platform.
As of September 2026: Using myoncare requires Windows 11 (or later), macOS 15.06 (or later) or Ubuntu 22.04 (or later), a stable internet connection of at least 10 Mbit/s with a maximum latency of 200 ms, and the latest version of the Chrome or Firefox browser. To use it on a tablet you need at least iOS 18.3.1 or Android 13.0. Your instance is hosted on an EU server of a company validated by us — with nothing for you to do. Your patients need a smartphone with an internet connection and at least iOS 18.3.1 or Android 13.0. Setting up interfaces to a hospital information system or other systems involves additional effort and cost.[
Bring your product and your patient group. In a short call we will sketch out what a companion for your therapy looks like, which clinical partners it would run in, and what evidence you get back.
Let's talk